Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Clinical trial NCT05595109 · UNKNOWN

Trial details

NCT number: NCT05595109
Sponsor: Tanta University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Breast Cancer Peripheral Neuropathy Cardiac Toxicities Hepatic Toxicity Cognitive Impairment

Start date: 2022-10-28
Primary completion: 2023-04-28
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.